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ABSTRACT
Predictors of Treatment Attendance and Adherence Among Individuals Receiving
Cognitive Behavioral Therapy for Insomnia
Ruifeng Cui
Rates of Insomnia Disorder have been found to be as high as 10% in the general population.
Cognitive Behavioral Therapy for Insomnia (CBT-I) is an effective treatment for insomnia.
Problematically, low rates of treatment attendance and adherence are common in CBT-I and
negatively impact treatment outcomes. The present study examined predictors of attendance and
adherence in a sample of adults receiving CBT-I. Identifying common predictors may help
researchers in designing more effective CBT-I treatments. Participants were 108 community
dwelling adults aged 19-95 who met criteria for Insomnia Disorder. The sample was comprised
of primarily female (71.3%) middle age (M = 50.5, SD = 14.6), Caucasian (92.6%) adults.
Younger adults and adults with greater depression and anxiety symptoms were less likely to
attend three or more sessions or complete CBT-I treatment. Additionally, younger adults were
less likely to adhere to a consistent bed time and wake time, i.e., younger adults had greater
variation in when they first went to bed at night and got out of bed in the morning. The present
study found that younger adults and those with greater comorbid psychiatric symptom severity
(i.e., depression and anxiety symptoms) were less likely to attend CBT-I treatment. Further,
among patients who attended CBT-I treatment, younger adults were less likely to adhere
consistently to a recommended bed time and wake time. Assessing for and addressing elevated
depression and anxiety levels prior to CBT-I treatment may facilitate treatment attendance.
Future research may investigate mediators of the relationship between age and CBT-I treatment
utilization.
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Predictors of Treatment Attendance and Adherence Among Individuals Receiving
Cognitive Behavioral Therapy for Insomnia
“Showing up is 80 percent of life,” a quote commonly attributed to Woody Allen,
succinctly describes the importance of effort, motivation, and literally showing up as it relates to
success in life. The problem of not showing up is particularly relevant to the successful treatment
of mental health disorders such as Insomnia Disorder. A meta-analysis conducted by Swift and
Greenberg (2012) found that one out of every five clients prematurely discontinues
psychotherapy. However, much higher rates of premature discontinuation have been found in
clinical treatment studies for Insomnia Disorder (33% Espie et al., 2008; 53%, Espie et al., 2007;
34%, Morgan, Thompson, Dixon, Tomeny, & Mathers, 2003).
Insomnia is a prevalent problem among adults and older adults. Insomnia has been
defined as having difficulty initiating sleep, maintaining sleep, or waking up too early despite
having the opportunity to sleep with this difficulty causing significant distress or impairment in
functioning (American Psychiatric Association, 2013). Insomnia rates of between 10-37% have
been found among individuals 18 and older (Morin, LeBlanc, Daley, Gregoire, & Merette, 2006;
Morphy, Dunn, Lewis, Boardman, & Croft, 2007). Further, an epidemiological study conducted
by Ohayon (2002) found that more than 50% of older adults (ages 65+) suffer from symptoms of
insomnia. Among individuals with insomnia, 25-33% have primary insomnia while the rest have
secondary insomnia, i.e. insomnia caused by another mental or physical illness (American
Psychiatric Association, 2000; Espie et al., 2007; Roth & Roehrs, 2003).
Insomnia has been linked to decreased productivity in the workplace, a lower quality of
life, a greater economic burden, and an increased risk of mortality for individuals (Bolge, Doan,
Kannan, & Baran, 2009; Dew et al., 2003; Ozminkowski, Wang, & Walsh, 2007). Insomnia has
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been found to be associated with a number of mental and physical illnesses (Taylor, Lichstein, &
Durrence, 2003; Taylor et al., 2007) as well as increased health care utilization (Daley et al.,
2009). A treatment study conducted by Espie and colleagues (2007) found that 40% of
participants had a co-occurring physical health problem and 58% had a co-occurring mental
health problem with the two most common mental disorders being depression and anxiety.
Further, insomnia increases the risk of developing both depressive disorders (Cole, & Dendukuri,
2003; Riemann & Voderholzer, 2003) and anxiety disorders (Neckelmann, Mykletun, & Dahl,
2007).
Treatments for insomnia
Pharmacotherapy is the most common treatment utilized by individuals suffering from
insomnia (National Institutes of Health, 2005). A survey conducted by Leger and Poursain
(2005) found that 95% of individuals in the United States who were severely impacted by their
symptoms of insomnia consulted a physician and among those who consulted a physician, 95%
were given a prescription for sleep medication. Although pharmacotherapy is effective at treating
insomnia in the short term (Smith et al., 2002), there are problems with long term usage of
medications for insomnia as some individuals develop a tolerance and insomnia often resumes
after discontinuation of the medications (National institutes of Health, 2005; Tariq & Pulisetty,
2008). Other downsides of pharmacological treatment include increased risk for accidents,
especially when individuals take prescription sleep medications too late in the evening without
sufficient opportunity to sleep (Gustavsen et al., 2008; Verster et al., 2002). Ambien, a common
prescription medication for insomnia, is also on the Beers Criteria for Potentially Inappropriate
Medication Use in Older Adults as its potential for harm greatly outweighs the limited benefits
for improving insomnia (Samuel, 2015).
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A nonpharmacological option for treating insomnia is Cognitive Behavioral Therapy for
Insomnia (CBT-I). CBT-I is a multicomponent treatment that targets the theorized underlying
factors that perpetuate insomnia in individuals, e.g., engaging in activities in the bed besides
sleep and sex which weakens the association between bed and sleep (stimulus dyscontrol),
extending sleep opportunity which decreases sleep drive, poor sleep hygiene, catastrophic
thoughts about consequences of poor sleep (Perlis, Jungquist, Smith, & Posner, 2006). CBT-I
typically consists of stimulus control and sleep restriction or compression. Stimulus control is
used to strengthen the association between bed and sleep (i.e., don’t engage in any activities in
the bedroom except for sleep and sex and get out of bed after 15 minutes of being awake). Sleep
restriction or compression is used to limit a person’s sleep opportunity in order to consolidate
their sleep (i.e., set a consistent bed and wake time for every day of the week that restricts their
sleep opportunity). CBT-I also teaches clients sleep hygiene habits (e.g., create a comfortable
sleeping environment, don’t take naps in the daytime, etc.) and cognitive restructuring
techniques to challenge catastrophic thoughts regarding failing to get a good night’s sleep.
CBT-I is successful at treating insomnia among adults and older adults (Edinger &
Means, 2005; Irwin, Cole, & Nicassio, 2006; Montgomery & Dennis, 2004). A study conducted
by Jacobs and colleagues (2004) demonstrated that CBT-I is more effective than
pharmacotherapy at reducing sleep onset latency, increasing sleep efficiency, and sustaining
treatment gains among adults. CBT-I has also been shown to be more effective than Zopiclone in
improving sleep efficiency among older adults (Sivertsen et al., 2006). Additionally, CBT-I has
been shown to be effective at treating secondary insomnia and insomnia comorbid with medical
or physical health problems (Edinger et al., 2009; Kohn & Espie, 2005; Morin et al., 2006;
Stepanski & Rybarczyk, 2006). CBT-I is preferred over pharmacotherapy by individuals with
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insomnia (Vincent & Lionberg, 2001). Further, the National Institutes of Health, the American
Academy of Sleep Medicine's Practice Parameters, and the American College of Physicians have
endorsed CBT-I as the first line treatment for individuals with chronic primary insomnia
(Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., & Denberg, T. D., 2016; Smith &
Perlis, 2006). Studies have found that, on average, patients receiving CBT-I experienced at least
a 50% decrease in wake after sleep onset and a 26% to 65% decrease in sleep onset latency
(Edinger & Means, 2005). A group CBT-I treatment study by Backhaus and colleagues (2001)
found that participants’ sleep continued to improve after the end of treatment with their total
sleep time increasing from 298 minutes at baseline to 351 minutes at end of treatment and 379
minutes by the one-year follow-up period. Another group CBT-I treatment study also found that
total sleep time improved in the one year follow up period during which time 84% of participants
who were using hypnotics at baseline were no longer using hypnotics (Espie, Inglis, Tessier, &
Harvey, 2001).
Attendance and adherence in insomnia treatment
Although CBT-I is an efficacious treatment for insomnia, the effectiveness of CBT-I is
hindered by high rates of attrition during treatment. Past insomnia treatment research has defined
attendance in different ways, such as a dichotomous variable specifying completion (attended all
sessions) vs non-completion/dropout (failed to attend all sessions; Edinger, Wohlgemuth,
Radtke, Marsh, & Quillian, 2001) or a dichotomous variable specifying attendance at a specific,
prerequisite number of sessions (e.g., four or more sessions, Ong et al., 2008), or a continuous
variable of number of sessions attended (Morin et al., 1999). The most common attendance
definition used is completing all treatment sessions. Low attrition rates have been found in many
CBT-I efficacy studies (e.g., 92% treatment completion rate, Edinger et al.,2001; 97% average
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session attendance rate, Morin, Colecchi, Stone, Sood, & Brink, 1999; 100% treatment
completion rate, Sivertsen et al., 2006) which typically use homogenous samples and have strict
inclusion and exclusion criteria. Commonly excluded participants include those who are
pregnant, have sleep apnea, have comorbid mental or medical disorders, who are using sleep aid
medications, who are using psychiatric medications, and who are in psychotherapy. Clinical
studies with less strict inclusion and exclusion criteria (e.g., allowing individuals with comorbid
mental or physical illness and/or individuals using hypnotic medications to participate) have
found higher rates of attrition (e.g., 67% completion rate, Espie et al., 2008; 47% attended 5 of
the 5 sessions, Espie et al., 2007; 66% attended 6 of the 6 sessions, Morgan et al., 2003). The
high rates of attrition found in CBT-I treatment studies utilizing more heterogeneous and
generalizable samples is problematic because studies have shown that higher rates of attendance
in CBT-I sessions is associated with better treatment outcomes (Edinger, Wohlgemuth, Radtke,
Coffman, & Carney, 2007; Espie et al., 2007).
Another potential problem in CBT-I treatment is patients’ adherence to treatment
recommendations. Studies using self-report ratings of treatment adherence have generally shown
high self-reported treatment adherence (e.g., adhering to treatment recommendations 6 out of 7
days, Edinger et al., 2009; compliance rated a 4 on a 5 point scale; Morin et al., 1999;
compliance rated 4.8 on a 5 point scale, Sivertsen et al., 2006). Although self-reported measures
of adherence utilizing self-report rating scales are generally high, other measures of adherence
have been less positive. Objective measurement of adherence has typically been defined as a
continuous variable of variation in times that the participants got into bed at night with the
intention of going to sleep and variation in times that the participant got up from bed for the last
time with the intention of not returning to bed to sleep more (Riedel & Lichstein, 2001; Vincent
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& Hameed 2003). In a CBT-I group treatment study conducted by Vincent and Hameed (2003),
only 48% of participants were rated by therapists as very much or extremely adherent to
treatment. A study conducted by Riedel and Lichstein (2001) found that patients stayed in bed 28
minutes longer than prescribed. This is not surprising since participants have rated sleep
restriction as their least favorable piece of CBT-I treatment (Vincent & Lionberg, 2001).
Adherence to CBT-I treatment recommendations is important as it is associated with better
outcomes (Edinger & Means, 2005; Riedel & Lichstein, 2001; Vincent & Hameed, 2003).
Behavioral Model of Health Care Utilization
Identifying predictors of health care utilization can allow researchers to design more
effective CBT-I treatments with better rates of attendance and adherence. The Behavioral Model
of Health Care Utilization created by Andersen (1995) has been used as a conceptual framework
for organizing and investigating multiple variables related to treatment utilization. These
variables are classified into three categories: predisposing, enabling, and need factors.
Predisposing factors are individual characteristics that predict an individual’s utilization
of treatment services. These factors include demographic related factors (e.g., age, gender) which
represent stable biological and physical characteristics as well as social status related factors
which indicate a person’s status in their community (e.g., ethnicity, education), both of which
may predispose them to be more likely to utilize treatment. A separate model consistent with the
Andersen model is the Health Belief Model, which states that these demographic characteristics
influence predisposition to utilize treatment by influencing an individual’s perceived barriers to
treatment utilization and/or perceived severity of disease (Martin, Haskard-Zolnierek, &
DiMatteo, 2010). Certain types of individuals, e.g., minorities, may have more barriers or
perceived barriers to treatment utilization and may be more susceptible or perceive themselves to
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be more susceptible to developing an illness or having a worse prognosis for an illness
(Bosworth, Oddone, & Weinberger, 2006).
Enabling factors are factors that may facilitate or hinder an individual’s ability to receive
and follow through with treatment. These include community factors (e.g., health care facility
within travel distance), social support factors (e.g., marital status), and personal factors (e.g.,
employment, health insurance, self-efficacy, co-occurring physical and/or mental health
problems). Consistent with the Health Belief Model, these enabling factors would either increase
the patient’s perceived ability to utilize and engage in treatment and the lack of said factors
would be perceived by the patients as barriers to obtaining treatment (Martin et al., 2010). A
supportive partner, for example, can provide instrumental support, e.g., transportation to
treatment and emotional support, e.g., help motivate the patient to adhere to tough treatment
recommendations.
Need factors consist of both the individual’s perception and treatment provider’s
perception of the severity of the symptoms experienced by the individual. Also consistent with
the Andersen model, the Health Belief Model predicts that the greater the perceived symptom
severity and/or severity of prognosis of their disease, the greater the intention to utilize health
care services (Martin et al., 2010).
Predictors of treatment attendance and adherence
Anderson’s (1995) treatment utilization model is well validated with many of its
specified predictor variables having been found to be predictive of attendance in psychotherapy
treatment. In general, psychotherapy research has found predisposing factors to be most
consistently related to treatment attendance. Specifically, older adults, Caucasians, females and
adults with more education were more likely to stay in psychotherapy treatment (Barrett, Chua,
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Crits-Christoph, Gibbons, & Thompson, 2008; Reis & Brown, 1999; Swift & Greenberg, 2012;
Wierzbicki & Pekarik, 1993). Older adults may be less geographically mobile as they may not
need to move around as much for work or school and older adults may have a stronger social
support network, two factors which may increase the likelihood of remaining in treatment
(Baekeland & Lundwall, 1975). Caucasians may be more likely to remain in therapy as
compared to minorities due to potentially differing expectations and needs of minority patients
(Sue, 1977). Females may be more likely to attend and stay in psychotherapy as compared to
males due to differences in socialized gender roles. Female gender roles include greater
acceptability of expressing emotions and depending on others, especially for help with mental
health concerns, while male gender roles emphasize emotional restrictiveness and independence,
which is less likely to promote help seeking, especially for mental health concerns (Good, Dell,
& Mintz, 1989). Greater education may be associated with more willingness to attend to
psychological wellbeing as well as greater verbal skills to comprehend the concepts presented in
psychotherapy (Baum & Felzer, 1964; Brill & Storrow, 1960).
Enabling resources such as higher social support and higher socioeconomic status (SES)
are associated with lower psychotherapy attrition (Barrett et al., 2008; Self, Oates, Pinnock‐
Hamilton, & Leach, 2005; Reis & Brown, 1999; Wierzbicki & Pekarik, 1993). The decreased
attrition among individuals with higher SES can be explained by the crisis reactive nature of
individuals who are economically disadvantaged. These individuals face so many life stressors
on a daily basis that they only have time to attend to critical life stressors and mental health
concerns many times do not reach the level of critical stressor as compared to other ongoing
stressors in their lives (Lorion, 1974). Social support in the form of emotional support may
enhance motivation for attending treatment and instrumental social support may assist in being
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able to attend treatment such as fulfilling transportation needs (Hays, Chauncy, & Tobey, 1990;
Rabkin, Williams, Neugebauer, Remien, & Goetz, 1990).
In contrast to the predictions of the Anderson model, research with regard to need factors
indicates that lower psychiatric symptomology and psychology distress is associated with lower
psychotherapy attrition (Barrett et al., 2008; Derisley & Reynolds, 2000; Pekarik, 1992). A
degree of symptom severity and impairment may be needed to serve as a motivator to attend
therapy however severe symptoms or disorders may impact the individual’s capability to address
their mental health concern and seek out psychotherapy services (Edelman & Chambless, 1993;
Holdsworth, Bowen, Brown, & Howat, 2014).
Research into predictors of adherence to CBT instructions have been more limited and
less systematic. Most research comes from single treatment studies of specific disorders (e.g.,
depression, anxiety, substance use). The most common predisposing factors that have been
investigated were age, gender, and education. With the exception of one study which found older
adults to be more adherent to homework assignments in CBT for panic disorder (Schmidt &
Woolaway-Bickel, 2000), CBT treatment studies for anxiety, depression, and substance use have
found no relation between age and adherence (e.g., Bryant, Simons, & Thase, 1999; Funk,
Zvolensky, & Schmidt, 2011; LeBeau, Davies, Culver, & Craske, 2013). One CBT study of
community CBT therapist’s ratings of patient adherence found women to be more adherent to
homework tasks (Helbig & Fehm, 2004) however numerous CBT treatment studies of
depression, anxiety, and substance use have not found any relation between gender and
adherence (e.g., Decker et al., 2016; LeBeau et al., 2013; Sasso, Strunk, Braun, DeRubeis, &
Brotman, 2015). CBT studies generally did not find a relation between education and adherence
(e.g., Gonzalez, Schmitz, & DeLaune, 2006; Weck, Richtberg, Esch, Höfling, & Stangier, 2013)
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except for one CBT treatment study of depression which found higher education level to be
associated with greater homework adherence (Burns & Spangler, 2000). Certain individual
characteristics and certain types of people may be more likely to attend therapy, however among
individuals in therapy, these characteristics may be less useful in predicting whether they will
adhere to therapy recommendations. In addition to negatively impacting treatment attendance,
limited enabling resources such as lack of social support, lack of self-efficacy, financial
limitations have been hypothesized to negatively impact treatment adherence (Bosworth et al.,
2006; Martin et al.,2010). CBT treatment studies typically do not assess for common enabling
factors such as social support, socioeconomic status, and self-efficacy in relation to adherence
(e.g., Fehm & Mrose, 2008; Rees, McEvoy, & Nathan, 2005; Sachsenweger, Fletcher, & Clarke,
2015; Willner‐Reid et al., 2016). Enabling factors with respect to adherence thus represents a
large gap in the literature that needs to be addressed. Need factors, specifically, pre-treatment
symptom severity, have been investigated in CBT treatments for depression, anxiety, and
substance use which generally show no relation between initial symptom severity and level of
adherence during treatment (e.g., Burns & Nolen-Hoeksema, 1991; Edelman & Chambless,
1995; Gonzalez et al., 2006; Rees et al., 2005). Similar to predisposing characteristics, need
characteristics may be useful in predicting whether individuals attend therapy, however among
those who do attend therapy, symptom severity may not be as useful in predicting whether these
individuals will adhere to therapy recommendations.
Researchers have utilized the Anderson (1995) model to predict utilization of a number
of different types of treatment. These include complementary and alternative medicine treatment
(Brown, Barner, Bohman, & Richards, 2009), Human Immunodeficiency Virus treatment
(Anthony et al., 2007), anxiety disorder treatment (Keyes et al., 2008), panic disorder treatment
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(Goodwin & Andersen, 2002), mood disorder treatment (Keyes et al., 2008), alcohol use disorder
treatment (Zemore, Mulia, Ye, Borges, & Greenfield, 2009), substance use disorder treatment
(Keyes et al., 2008), depression and substance use disorder treatment (Tate et al., 2011), and
substance use and PTSD treatment (Cui et al., 2016).
There is limited research regarding predisposing, enabling, and need factors associated
with CBT-I treatment attendance and adherence. With respect to predisposing factors, females
were more likely than males to remain in Dashevsky and Kramer’s (1997) treatment study
investigating the effectiveness of combined CBT-I and pharmacotherapy treatment for insomnia
symptoms among individuals with psychiatric illnesses. To be included, participants must have
failed to respond to psychotropic medications for insomnia and have one or more psychiatric
diagnoses. A group cognitive behavioral treatment for insomnia study found older participants to
be more adherent to a consistent wake time (Vincent, Lewycky, & Finnegan, 2008). The study
utilized a community sample and only excluded individuals with shift work, schizophrenia,
bipolar disorder, and/or head injuries however the analyses predicting adherence was only
conducted on a subset of the sample, i.e., those who have completed the study (Vincent et al.,
2008).
Several studies have investigated enabling factors associated with CBT-I treatment
utilization. Individuals with insomnia and no co-occurring physical or mental health problem
were more likely to complete CBT-I treatment for insomnia as compared to individuals with
mental or physical health comorbidities in Dashevsky and Kramer’s (1997) study of combined
CBT-I and pharmacotherapy treatment for insomnia. Vincent and Hameed (2003) conducted a
study investigating adherence to CBT-I group treatment which excluded individuals who showed
symptoms of other sleep disorders (e.g., sleep apnea), had traumatic brain injuries, had bipolar
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disorder, had schizophrenia, or had medical conditions (e.g., pain). They found that individuals
without a comorbid dysthymia disorder received higher ratings of adherence from therapists
during treatment as compared to individuals with a comorbid dysthymia disorder. Lower cooccurring depressive symptom severity was also found to be associated with greater adherence to
a fixed wake time as well as greater adherence to a set time to be spent in bed in the group CBT-I
study conducted by Manber and colleagues (2011). Although the sample used was a community
sample which did not exclude co-occurring psychiatric or medical disorders, the adherence
analyses was only conducted on the subset sample of treatment completers. A study conducted
by Bouchard and colleagues (2003) investigated the relation between self-efficacy and adherence
to CBT-I treatment for insomnia and found that having higher levels of self-efficacy was
associated with increased adherence to CBT-I treatment components. Their treatment study had
excluded individuals with sleep apnea, with restless legs syndrome, using sleep medications, in
psychotherapy, and with co-occurring mental and/or physical health conditions.
Lastly, several need factors relating to sleep problem severity have been found to be
associated with CBT-I treatment utilization. Having lower fatigue during the baseline time
period was associated with a greater likelihood of completing Dashevsk and Kramer’s (1997)
combined CBT-I and pharmacotherapy treatment study. Morgan and colleagues (2003)
conducted a study investigating predictors of attrition in CBT-I treatment with a sample of
individuals using prescription sleep aids. Their study found that individuals with more severe
sleep disturbances at treatment entry were more likely to remain in CBT-I treatment. A study
conducted by Ong and colleagues (2008) found that individuals with more total sleep time at the
start of treatment were more likely to complete CBT-I treatment. The inclusion and exclusion
criteria for their participant sample was not reported. These studies suggest that more severe
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insomnia symptoms (e.g., sleep disturbances) at treatment entry may be associated with a greater
perception of need for insomnia treatment and facilitate treatment completion. However, more
severe insomnia symptoms (e.g., greater daytime fatigue, less total sleep time) may also act as
enabling factors that hinder an individual’s ability to engage in treatment.
Statement of the problem and hypotheses
A model of treatment utilization proposed by Andersen (1995) identifies a number of
variables to be predictive of treatment utilization which are conceptualized into three categories,
predisposing, enabling, and need factors. Generally in psychotherapy research, predisposing
factors of age, gender, ethnicity, and education, enabling factors of social support and
socioeconomic status, and need factors of symptom severity and distress have been found to be
associated with treatment utilization. With respect to CBT-I treatment research, the predisposing
factor of gender, the enabling factor of co-occurring physical or mental health problems, and the
need factor of insomnia symptom severity have been found to be associated with CBT-I
treatment attendance. Further, the predisposing factor of age, enabling factors of depression,
motivation, and self-efficacy, and the need factor of fatigue were found to be associated with
CBT-I treatment adherence. However, to date, all the insomnia treatment studies that have
investigated predictors of treatment attendance and treatment adherence have used strict
inclusion and exclusion criteria and/or conducted adherence analyses only with the treatment
completer subset of the sample, which limit the generalizability of the findings to community
populations with insomnia. It is also unknown if factors that were found to be unrelated to
treatment attendance utilizing restrictive homogeneous samples or factors unrelated to adherence
utilizing only treatment completers will be predictive of treatment attendance and/or adherence
in a more heterogeneous sample of treatment seekers that more closely resembles community
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populations with insomnia. Additionally, CBT-I treatment attendance has been defined multiple
ways (e.g., attend all sessions, Eddinger et al., 2001; attend a certain number of sessions, Ong et
al., 2008; number of sessions attended, Morin et al., 1999) and it is unknown if factors found to
be predictive of attendance defined as having attended all sessions will still be predictive when
operationalized as having attended a minimal number of sessions or operationalized as a count
number of sessions attended.
The proposed study investigated a variety of predisposing, enabling, and need variables
as predictors of CBT-I treatment attendance and adherence in a primary care treatment setting.
The study examined predictors of both attendance and adherence utilizing a well validated model
of treatment utilization (Andersen, 1995) as a conceptual framework for understanding and
organizing predictor variables. Some researchers have conceptualized attendance as another
measure of adherence to therapist recommendations (e.g., Taft, Murphy, King, Musser, &
DeDeyn, 2003) however for the purposes of this study, attendance and adherence are
investigated as separate constructs consistent with much of the literature on CBT-I treatment
(e.g., Matthews, Arnedt, McCarthy, Cuddihy, & Aloia, 2013). The following predisposing,
enabling, and need factors are hypothesized to be associated with treatment attendance based on
previous psychotherapy attendance research and CBT-I attendance research. Predisposing factors
of being older, female, white, and having more education are predicted to be associated with
greater treatment attendance. Enabling factors of having fewer co-occurring mental and/or
physical health problems, having greater social support, and being employed are predicted to be
associated with greater treatment attendance. Need factor of greater insomnia symptomology is
predicted to be associated with greater treatment attendance. There is limited research regarding
consistent predictors of treatment adherence in psychotherapy treatments in general and the
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CBT-I adherence research is also limited and have typically used a treatment completion sample
which hinders the interpretation of their findings. Consequently, exploratory analyses
investigated predisposing, enabling, and need factors as they relate to treatment adherence
however no hypotheses are made regarding these relations.
This study has unique strengths which address several limitations in the present literature.
The majority of participants in this study were referred by a health care provider with only one
patient having been self-referred to the clinic. As many individuals first seek treatment for
insomnia from a health care provider (Leger & Poursain, 2005), the recruitment process utilized
in the study supports the validity of the findings. The generalizability of the findings is further
supported through the use of minimal inclusion and exclusion criteria for participant recruitment
and statistical analyses. The present study examined adherence as two separate continuous
variables, variation in time that the participant got into bed with the intention of sleeping (bed
time) and variation in time that the participant woke up and got out of bed with the intention of
no longer sleeping (wake time). Since there is no established definition of attendance in the field
of insomnia treatment research, the present study examined attendance as two categorical
variables, attend three or more sessions vs attend two or fewer sessions and attend all
recommended sessions vs did not attend all recommended sessions as well as a continuous
variable of number of sessions attended among individuals who did not attend all recommended
sessions. The distinction between three or more sessions vs two or fewer sessions was made
because the core components of CBT-I, i.e., sleep restriction, stimulus control, and sleep
hygiene, are introduced during the first three sessions (Perlis et al., 2006).
Method
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Participants and procedures
Participants were 156 outpatients from the Clark K. Sleeth Family Medicine Center
Insomnia Clinic in Morgantown, West Virginia. Participants were recruited between 2009 and
2016. Morgantown is located in Monongalia County, which is comprised of both urban and rural
communities with residents from diverse socioeconomic backgrounds. The patients seen at the
clinic come from Monongalia County as well as other surrounding counties as the present study
did not have a distance exclusion criterion. Participants were individuals referred by their general
practitioners if they expressed sleep problems and were interested in receiving psychotherapy for
insomnia. Patients were not charged any fees to be seen at the Insomnia Clinic. Individuals were
screened for eligibility to receive CBT-I treatment during a one-hour intake interview.
Participants were not compensated for attending therapy sessions, completing questionnaires, or
completing home assignments. Additionally, participants were not reimbursed for cost of travel
(e.g., gas for miles driven, bus tokens). All study procedures were approved by West Virginia
University’s Institutional Review Board.
All 156 participants had attended at least the intake interview session at the Insomnia
Clinic. The data for the present study consist of information the patients provided during routine
clinical care at the Insomnia Clinic. Additionally, ethnicity, gender, type of insurance, health
conditions, and progress notes were obtained through chart reviews.
An effort was made to determine how many people were referred but did not attend even
one session. During the recruitment time period, a subset of individuals referred to the clinic did
not follow through with the referral and were thus not recruited for this study. Data on follow
through with referral were available for the June 2015 to June 206 timeframe during which time
49 individuals were referred to the clinic of whom nine did not attend any sessions.
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Inclusion criteria were: a) at least 18 years of age and b) current diagnosis of primary or
secondary insomnia based on DSM-IV-TR (American Psychiatric Association, 2000) or DSM-V
(American Psychiatric Association, 2013) criteria. Participants were excluded if they a) had a cooccurring psychiatric or medical condition that would make participation unfeasible, or b) had a
co-occurring sleep-wake disorder that was not being adequately managed. Eligible participants
who agreed to participate in the treatment provided written informed consent to receive CBT-I
treatment in the first session. The final sample consisted of 108 participants. Reasons for
exclusion are presented in Figure 1.
Insomnia diagnoses. The diagnosis of insomnia disorder was made using information
obtained at intake from a semi-structured interview as well as information obtained from a
review of the participant’s medical charts and from the participant’s self-report assessment
measures. Diagnosis of insomnia for participants was based on either DSM-IV-TR or DSM-5,
which was published in 2013. Diagnostic criteria for Primary Insomnia based on the DSM-IVTR are as follows: for one month, the individual has difficulty falling or staying asleep or their
sleep is nonrestorative and these symptoms cause significant distress or impairment. The DSM-5
criteria for Insomnia Disorder are more specific, requiring sleep problems to be present for at
least three nights per week for at least three months despite having sufficient opportunity to
sleep. Sleep problems are defined as difficulty falling asleep, staying asleep, and/or waking
earlier than intended and having difficulty falling back asleep and these sleep problems must
cause significant distress or impairment.
Cognitive Behavioral Therapy for Insomnia
CBT-I provided in this study was based on Perlis and colleagues’ (2006) Cognitive
Behavioral Treatment of Insomnia manual. In the current study, CBT-I was comprised of four

ATTENDANCE AND ADHERENCE IN INSOMNIA TREATMENT

18

components from Perlis and colleagues’ (2006) manual, which are stimulus control, sleep
restriction, sleep hygiene, and cognitive restructuring. Additionally, the CBT-I used in this study
includes an added component of progressive muscle relaxation that was not part of the manual.
CBT-I consists of at least six 60-minute sessions provided approximately once every week to
every two weeks depending on clinic availabilities and the availabilities of the participants.
Depending on mitigating factors such as severity of the participant’s insomnia, whether
participants wanted assistance in titrating off sleep aids, and/or presence of co-occurring physical
or mental health problems, additional therapy sessions were provided as needed. Treatment
sessions were heavily structured and provided in a didactic format. Sleep diaries would be
provided at the end of every treatment session and reviewed at the beginning of every treatment
session. Participants were tasked with providing sleep diary data for every day during the
treatment period. If a participant wished to titrate off their sleep aid, the therapist worked with
the participant and the participant’s primary care provider to create an individualized titration
plan and incorporate it into their treatment.
The majority of participants received individual CBT-I treatment (individual CBT-I =
101 participants, group CBT-I = 7 participants). Group CBT-I differed from individual CBT-I in
that individuals would meet with a therapist one on one for their first intake session and for the
rest of their therapy sessions, they would meet for a few minutes with their therapist before the
group treatment started so that their therapist can review their sleep diary with them and adjust
their sleep prescription after which the individual would meet with their therapist in a group
setting with other patients.
CBT-I was implemented by graduate student trainees enrolled in an APA-accredited
clinical psychology doctoral training program. The Insomnia Clinic team consisted of a licensed
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clinical psychologist who is certified in behavioral sleep medicine and a mid-level supervisor
who was an advanced graduate student, a graduate student intern, or a postdoctoral fellow, and
two to three first- or second-year graduate students. All therapies were provided by first- or
second-year graduate students who were trained and supervised by the licensed psychologist and
the mid-level supervisor. Supervisors observed the first- and second-year graduate students either
in person or via live stream from a monitor. Supervision was provided in group format to
trainees after live observation of therapy sessions conducted by trainees.
Session 1-Intake. Prior to the intake session, the therapist reviewed the participant’s
medical charts. During the session, the therapist conducted an unstructured interview with the
participant. Additionally, the participant would complete several self-report questionnaires at the
beginning or end of the session. All information obtained was integrated to determine whether
the participant met criteria for insomnia. If the participant failed to meet criteria, they were
referred to primary care or a sleep clinic. If the participant met criteria for insomnia but had a cooccurring medical, psychiatric, or sleep-wake disorder that would make participation unfeasible,
the participant was advised to seek treatment for said disorders and return to clinic once their
other disorders were under control. At the end of the session, the participant would be provided
with their first sleep diary to track their sleep.
Session 2-CBT model. The therapist provided didactics on the Speilman model of how
insomnia develops. Specifically, the therapist explained how predisposing, precipitating, and
perpetuating factors function to trigger and maintain one’s insomnia as well as the rationale for
enacting stimulus control and following a sleep prescription. The therapist then provided the
patient with instructions to enact stimulus control (i.e., do not engage in any activities in the
bedroom except for sleep and sex, get out of bed after 15 minutes of being awake) and an
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individualized sleep prescription in the form of sleep restriction or sleep compression. Sleep
restriction consisted of restricting the participant’s time allotted to spend in bed to the average
amount of time they spend sleeping each night. Each week, if the participant’s sleep efficiency
(total sleep time/time in bed) was 85% or greater, they would gain an additional 15 minutes of
allotted time in bed. If the sleep efficiency was less than 80%, the participant’s time allotted to
spend in bed may be further restricted if early in treatment or in most cases, left the same . Sleep
compression consisted of restricting the participant’s time allotted to spend in bed by one fifth of
the difference between the total time that they spend in bed and their total sleep time until their
sleep efficiency is above 80% during the week. Then, if their sleep efficiency is above 85%
during the week, they would gain an additional 15 minutes of allotted time in bed and if their
sleep efficiency fell below 80% during the week, they would lose an additional 15 minutes. The
sleep prescription decisions were based on the individual’s sleep diary data collected between
session one and two. In each subsequent session, the sleep prescription would be adjusted as
necessary.
Session 3-Sleep hygiene. The therapist provided the participant with didactics on sleep
hygiene and a list of 14 sleep hygiene instructions (e.g., sleep only as much as you need, get up
at the same time each day, exercise regularly, etc.; Perlis et al., 2006). The therapist went through
the list of instructions, provided the rationale for following each of them, and advised the
participant to follow all 14 instructions. The amount of time spent discussing each instruction
depended on the participant’s interest and the relevance of the instruction to the participant.
Session 4-Progressive muscle relaxation. The therapist provided the rationale for doing
relaxation training and demonstrated how to do progressive muscle relaxation. The participant
practiced the technique and was then provided feedback from the therapist. Participants were

ATTENDANCE AND ADHERENCE IN INSOMNIA TREATMENT

21

instructed to practice doing progressive muscle relaxation at least once a day.
Session 5-Cognitive restructuring. The therapist worked with the participant to identify
and challenge maladaptive and inaccurate beliefs regarding the consequences of getting a poor
night’s sleep, with the goal of decreasing the participant’s anxiety and increasing the
participant’s adherence to the sleep prescription.
Session 6-Relapse prevention. The therapist reviewed with the patient the conceptual
model of how insomnia begins and the patient’s progress during treatment. The therapist
provided didactics on how to continue to self-monitor and adjust one’s sleep schedule. The
therapist also provided information on what to do to prevent a relapse from occurring, how to
determine if a relapse has occurred, and what to do in the event of a relapse.
Additional sessions may take place between the cognitive restructuring session and the
relapse prevention session if sufficient treatment gains have not been made by the participant
and/or if judged beneficial by the therapist. These additional sessions may include additional
sleep monitoring and modifications to the sleep prescription, teaching additional relaxation
techniques, and teaching skills to better manage other sleep-wake disorders (e.g., Imagery
Rehearsal Therapy skills to manage Nightmare Disorder). For additional information on the
treatment protocol, see Perlis and colleagues (2006). If the participant had failed to make
significant gains by the end of treatment, the participant was referred for additional evaluation, as
appropriate, such as a sleep study or medical evaluation.
Measures
Demographic variables were assessed at intake using a biological questionnaire
(Appendix H) and through chart review. Sleep diaries were completed throughout the treatment
period including at intake and end of treatment. All other measures were administered at intake
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and treatment completion. Missing information was obtained through chart review if possible.
Mean imputation of missing items on the sleep, depression, and anxiety measures was conducted
if the number of items missing was 20% or less. If the number of missing items was greater than
20%, the measure would be excluded from analyses.
Demographic Information. Demographic data consisted of age, gender (coded 1 = male,
0 = female), ethnicity (coded 1 = non-Hispanic white, 0 = other), level of education (coded 1 =
college or more, 0 = high school or less), employment status (coded 1 = working, 2 = not
working, 3 = retired, 4 = disabled), insurance status (coded 0 = private, 1 = Medicare, 2 =
Medicaid), marital status (0 = not married, 1 = married), number of co-occurring physical health
problems (Appendix I), and name of prescription sleep medications taken by participants. Age,
education level, employment status, and marital status were obtained from the biological
questionnaire. Age and marital status for six individuals, education level for four individuals, and
employment status for five individuals were obtained through chart review. Gender, ethnicity,
insurance status and name of prescription sleep medication were obtained through chart review
for every participant. Number of health problems was obtained from the Medical History
Information Form (Appendix I) based on how many health conditions the participants endorsed.
Twelve participants had completed the information form and the number of health conditions for
the remaining 96 participants was obtained through chart review based on how many of the
health conditions listed on the information form was listed as a diagnosis in the participant’s
medical records.
Epworth Sleepiness Scale (ESS; Appendix A; Johns, 1991). The ESS is a self-report
measure of average level of sleepiness during the day over the last one week period. The ESS is
comprised of eight items describing eight different frequently encountered situations.
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Participants would rate their likelihood of falling asleep in each situation on a scale of 0 = would
never doze to 4 = high chance of dozing. The ESS has demonstrated a test-retest reliability of .82
over a five month period and a Cronbach’s alpha of .88 (Johns, 1992). Scores of 10 or greater
have been used as an indication of clinically significant levels of daytime sleepiness (Buysse et
al., 2008). In the current study, the ESS was used as a continuous measure of severity of daytime
sleepiness. The Cronbach’s alpha for the ESS in this study was .88.
Insomnia Severity Index (ISI; Appendix B; Bastien, Vallières, & Morin, 2001). The ISI
is a brief self-report assessment of severity of insomnia symptoms. The ISI consists of seven
items assessing insomnia symptom severity and impact on life functioning on a scale of 0 =
none/not at all to 4 = very/very much. Cronbach’s alphas of .74 to .91 have been found for the
ISI (Bastien et al., 2001; Morin, Belleville, Bélanger, & Ivers, 2011). For detecting insomnia, a
score of 10 or higher was recommended as the cutoff in community samples and a score of 11 or
higher was recommended as the cutoff in clinical samples (Morin et al., 2011).
Recommendations for interpreting scores as an indication of insomnia severity are as follows: 0
– 7 = no insomnia, 8 – 14 = subthreshold insomnia, 15 – 21 = moderate insomnia, and 21 – 28 =
severe insomnia (Smith, & Wegener, 2003). The ISI was used as a continuous measure of
severity of insomnia symptoms. Mean imputation was used to impute missing items on the ISI
for two individuals. The Cronbach’s alpha for the ISI in this study was .75.
Pittsburgh Sleep Quality Index (PSQI; Appendix C; Buysse, Reynolds, Monk, Berman,
& Kupfer, 1989). The PSQI is a self-report measure of sleep quality and sleep disturbance over
the past one month period. The PSQI consists of 19 items rated on a 0 = not during the past
month to 3 = three or more times a week scale. The 19 items are used to calculate seven
component scores (sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep
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disturbances, use of sleeping medication, and daytime dysfunction) and a global rating of sleep
quality ranging from 0 to 21. The PSQI has demonstrated a Cronbach’s alpha of .83 and a testretest reliability of .85 over a 28 day period (Buysse et al., 1989). A global rating score five or
greater indicates clinically significant poor sleep quality indicative of the presence of a sleep
disorder (Buysse et al., 1989). The PSQI was used as a continuous measure of severity of sleep
disturbances. Mean imputation was used to impute missing items on the PSQI for 21 individuals.
The Cronbach’s alpha for the PSQI in this study was .53.
Beck Anxiety Inventory (BAI; Beck, Epstein, Brown, & Steer, 1988). The BAI is a selfreport measure of anxiety symptom severity during the past week. The BAI consists of 21 items
of anxiety symptoms rated on a scale of 0 = not at all to 3 = severely, could barely stand it, based
on how much each symptom bothered the individual. A test-retest reliability of .75 over a one
week period and a Cronbach’s alpha of .92 have been found for the BAI (Beck et al., 1988).
Scores between 10 and 18 suggests mild anxiety and scores of 19 and above suggest moderate
anxiety (Kabacoff, Segal, Hersen, & Van Hasselt, 1997). The BAI was used as a continuous
indicator of anxiety symptom severity. Mean imputation was used to impute missing items on
the BAI for five individuals. The Cronbach’s alpha for the BAI in this study was .91.
Center for Epidemiologic Studies Depression - Revised (CESD-R; Appendix D;
Eaton, Smith, Ybarra, Muntaner, & Tien, 2004). The CESD-R is a self-report measure of level of
depressive symptoms. The assessment consists of 20 items describing depressive symptoms that
are rated for how often they were experienced during the past week on a scale of 0 (not at all or
less than 1 day) to 3. The last two items of the scale, “5-7 days” and “nearly every day for 2
weeks,” were both scored as a 3 based on scoring procedures described by Van Dam and
Earleywine (2011). A Cronbach’s alpha of .93 has been found for the CESD-R (Van Dam &
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Earleywine, 2011). Scores of 16 or greater indicate probable depression (Eaton et al., 2004). The
CESD-R was used as a continuous measure of depressive symptom severity. Mean imputation
was used to impute missing items on the CESD-R for 17 individuals. The Cronbach’s alpha for
the CESD-R in this study was .92.
Sleep diaries (Appendix G). Diaries were completed by participants at every session
following intake. Sleep diaries were reviewed with participants at the beginning of every session
and used to revise the participant’s sleep prescription as needed. Sleep diaries provided the
following sleep parameter data: fatigue level, frequency and duration of naps, usage of
medications and/or substances, bed time, wake time, desired wake time, sleep onset latency,
wake after sleep onset, frequency of nocturnal awakenings, terminal wakeful time, total sleep
time, time in bed, and sleep efficiency. The accuracy of sleep diaries in measuring sleep
parameter data has been found to be similar to that of actigraphy (Vallières & Morin, 2003).
There was greater discrepancy between polysomnography and sleep diary on sleep onset latency
as compared to between polysomnography and actigraphy however there were no significant
discrepancies between polysomnography and sleep diary or between polysomnography and
actigraphy on total sleep time, sleep efficiency, and time in bed (Vallières & Morin, 2003). The
diary(s) completed by participants between session one and session two were used to assess
baseline sleep parameters, after which the rationale and recommendation for adhering to a
consistent bed and wake time was provided in session two. Forty-four individuals had completed
one or more sleep diaries for the weeks in which they had a recommended bed time and wake
time, i.e., weeks following session two (nine individuals had one diary, six individuals had two
diaries, two individuals had three diaries, eleven individuals had four diaries, twelve individuals
had five diaries, two individuals had six diaries, three individuals had seven diaries, and one
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individual had nine diaries). To maintain consistency across participants, the diary(s) completed
based on the first prescribed bed time and wake time, i.e., diary(s) completed for week(s)
between session two and session three, was used as the measure of adherence in this study. All
sleep diaries were entered by research assistants. Variation in bed times consisted of standard
deviation in times recorded in column A of the sleep diary, “Time you went to bed and turned
out lights,” and variation in wake times consisted of standard deviation in times recorded in
column D of the sleep diary, “Time you woke up this morning for the last time.”
Analyses
Predisposing, enabling, and need factors were used to predict treatment attendance and
treatment adherence. Treatment attendance consisted of two dichotomous outcome variables.
The first variable is coded 1 = attended at least three treatment sessions and 0 = attended fewer
than three treatment sessions. The second variable is coded 1 = attended all recommended
treatment sessions including relapse prevention and 0 = did not attend all recommended
treatment sessions. Participants were coded as having attended all recommended treatment
sessions if they attended the relapse prevention session since this session was always delivered as
the last session. Secondary analysis of attendance was conducted to predict number of sessions
attended among individuals who did not attend all recommended sessions. Treatment adherence
consisted of two outcome variables: a continuous variable of variation in bed time and a
continuous variable of variation in wake time, both measured in minutes. Variation in bed times
and wake times have been used as measures of adherence in multiple studies (e.g., Riedel &
Lichstein, 2001; Vincent & Hameed, 2003).
Predisposing predictors were comprised of age, gender, ethnicity, and education level.
Enabling predictors were comprised of employment status, number of physical health problems,
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insurance status, marital status, BAI, and CESD-R. Need predictors were comprised of PSQI,
ESS, ISI. All predictor measures used in the analyses were collected at baseline.
Separate logistic regressions were used to determine whether predictor variables were
associated with whether individuals attended three or more sessions versus two or fewer sessions
as well as whether individuals attended all recommended sessions versus did not attend all
recommended sessions. In logistic regressions, zero was used as the reference group for
categorical variables. Separate linear regressions were used to examine the relation between
predictor variables and number of sessions attended, variations in bed times, and variations in
wake times.
Separate multiple logistic regressions and multiple linear regressions were conducted
using predictors that were significant at the univariate level. Predisposing predictors that were
significant at the univariate level were entered in the multiple regression models in step one and
enabling predictors that were significant at the univariate level were entered into step two of the
multiple regression models to see if significant enabling predictors added any additional
predictive utility over and above significant predisposing predictors. Additionally, multiple
regression analyses were conducted where predisposing predictors that were significant at the
univariate level were entered into step one and need predictors that were significant at the
univariate level were entered into step two of the multiple regression models to see if need
predictors added any additional predictive utility over and above predisposing predictors.
Traditionally, it has been recommended to have 10 events per predictor in logistic regression
(Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996; Vittinghoff & McCulloch, 2007). For
the attending all sessions variable, there were only 26 events in the smallest group (attended all
recommended sessions group) and thus there was only sufficient power to investigate two
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predictor variables in a multiple logistic regression. Consequently, predictors for this variable
were only analyzed at the univariate level.
Results
Sample characteristics
The final sample was comprised of 108 participants. Participants were primarily female
(71.3%) middle aged (M = 50.5, SD = 14.6) Caucasian (92.6%) adults. Thirty three participants
were using prescription sleep medications at intake (one used Clonazepam [Klonopin], one used
Doxepin [Zonalon], one used Eszopiclone [Lunesta], six used Temazepam [Restoril], one used
Zaleplon [Sonata], and 23 used Zolpidem [Ambien]). Additional demographic information and
means and standard deviations for the variables of interest are presented in Table 1.
Participants completed on average 3.37 sessions (SD = 2.74) and the maximum number
of sessions a participant had completed was 11 sessions. Participants completed on average 2.22
sleep diaries (SD = 2.66), indicating that participants completed their assigned sleep dairies
93.67% of the time (participants were not given a sleep diary to complete and bring to the first
intake session). The majority of participants did not attend three or more sessions (50
participants attended three or more sessions) or complete treatment (26 participants attended all
recommended treatment sessions). On average, participants deviated from a consistent bed time
by 27 minutes (SD = 29.00) and deviated from a consistent wake time by 40 minutes (SD =
25.90). The majority of participants, 101 participants, received individual CBT-I while seven
participants received group CBT-I treatment. Participants receiving individual CBT-I did not
differ from participants receiving group CBT-I on any outcome measures (See Table 2). Multiple
imputation was used to deal with missing data in multiple linear regression and multiple logistic
regression analyses. All predictors of interest were normally distributed and all assumptions of
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multiple regression were met for the analyses conducted in this study. The relations among
continuous predictor variables are presented in Table 3.
Predictors of attending three or more sessions
Bivariate logistic regression models were used to investigate the relation between each
predictor variable and attending three or more sessions separately.
Predisposing factors. Age was significantly associated with attendance, N = 108, b =
0.04, Wald χ2(1) = 7.43, p < .01, with individuals attending three or more sessions being older on
average (mean age = 54.72, SD = 15.38) as compared to individuals attending two or fewer
sessions (mean age = 46.78, SD = 12.99). Education, ethnicity, and gender were not associated
with whether individuals attended three or more sessions (See Table 4).
Enabling factors. Anxiety symptoms were significantly associated with attendance, N =
103, b = -0.06, Wald χ2(1) = 7.53, p < .01, with individuals attending three or more sessions
having lower levels of anxiety symptoms (mean BAI score = 10.21, SD = 9.33) on average as
compared to individuals attending two or fewer sessions (mean BAI score = 16.36, SD = 11.32).
Additionally, depressive symptoms were significantly associated with attendance, N = 107, b = 0.04, Wald χ2(1) = 5.95, p = .01, with individuals attending three or more sessions having less
depressive symptoms on average (mean CESD-R score = 15.92, SD = 11.89) as compared to
individuals attending two or fewer sessions (mean CESD-R score = 22.16, SD = 13.15).
Employment status, number of co-occurring physical health problems insurance status, and
marital status were not associated with whether individuals attended three or more sessions (See
Table 4).
Need factors. No need factors were associated with whether individuals attended three or
more sessions (See Table 4).
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Combined model. A multiple logistic regression model was conducted where age was
entered into step one and anxiety and depressive symptoms were entered into step two of the
model. Multiple imputation was used to impute values for missing data. Twenty imputations
were run to impute six missing observations. In step one of the model, age was significantly
associated with attendance, b = 0.04, Wald χ2(1) = 7.43, p < .01, with the log likelihood of the
model being -70.41. In step two of the model, age remained significant, b = 0.04, p = .02, as did
anxiety symptoms, b = -0.07, p = .0497, however depressive symptoms were not significant, b =
0.01, p = .62, with the log likelihood of the model decreasing to -66.66 (see Table 5).
Predictors of attending all recommended sessions
Bivariate logistic regression models were used to investigate the relation between each
predictor variable and attending all recommended sessions separately.
Predisposing factors. Age was significantly associated with attendance, N = 108, b =
0.06, Wald χ2(1) = 10.51, p < .01, with individuals who attended all recommended sessions being
older on average (mean age = 59.27, SD = 13.61) as compared to individuals who did not attend
all recommended sessions (mean age = 47.66, SD = 13.88). Education, ethnicity, and gender
were not associated with whether individuals attended all recommended sessions (see Table 6).
Results for the ethnicity predictor should be interpreted with caution due to the smallest cell
containing only five individuals.
Enabling factors. Anxiety symptoms were significantly associated with attendance, N =
103, b = -0.07, Wald χ2(1) = 5.15, p = .02, with individuals who attended all recommended
sessions having less anxiety symptoms on average (mean BAI score = 9.06, SD = 7.54) as
compared to individuals who did not attend all recommended sessions (mean BAI score = 14.92,
SD = 11.38). Depressive symptoms were also significantly associated with attendance, N = 107,
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b = -0.07, Wald χ2(1) = 7.97, p < .01, with individuals who attended all recommended sessions
having less depressive symptoms on average (mean CESD-R = 12.77, SD = 10.11) as compared
to individuals who did not attend all recommended sessions (mean CESD-R score = 21.40, SD =
13.07). Employment status, number of co-occurring physical health problems, insurance status,
and marital status were not associated with whether individuals attended all recommended
sessions (see Table 6). Results for the employment predictor should be interpreted with caution
due to the second smallest cell containing two individuals and the smallest cell containing zero
individuals. Additionally, results for the insurance predictor should also be interpreted with
caution due to the second smallest cell containing six individuals and the smallest cell containing
zero individuals.
Need factors. Insomnia symptoms were significantly associated with attendance, N =
105, b = -0.12, Wald χ2(1) = 5.37, p = .02, with individuals who attended all recommended
sessions having lower levels of insomnia symptoms on average (mean ISI score = 17.85, SD =
4.79) as compared to individuals who did not attend all recommended sessions (mean ISI score =
20.30, SD = 4.35). No other need factors were associated with whether individuals attended all
recommended sessions (see Table 6).
Secondary analysis predicting number of sessions attended. Bivariate linear
regression models were used to investigate the relation between each predictor variable and
number of sessions attended separately among individuals who did not attend all recommended
sessions (Table 7). Among these individuals, only age was significantly associated with number
of sessions attended, t(80) = 2.25, p = .03, with older individuals having attended more sessions.
Predictors of adherence to consistent bed time
Bivariate linear regression models were used to investigate the relation between each

ATTENDANCE AND ADHERENCE IN INSOMNIA TREATMENT

32

predictor variable and consistency of bed times separately.
Predisposing factors. Age was significantly associated with standard deviation of bed
times, t(42) = -2.56, p = .01. Higher age was associated with greater consistency in going to bed
at the same time every day (i.e., lower standard deviation of bed times). Education, ethnicity, and
gender were not associated with consistency in bed times (see Table 8).
Enabling factors and need factors. No enabling or need factors were associated with
consistency in bed times (see Table 8).
Predictors of adherence to consistent wake time
Bivariate linear regression models were used to investigate the relation between each
predictor variable and consistency of wake times separately.
Predisposing factors. Age was significantly associated with standard deviation of wake
times, t(42) = -2.21, p = .03. Older individuals more consistently woke up at the same time every
day. Education, ethnicity, and gender were not associated with consistency in wake times (see
Table 9).
Enabling factors. Depressive symptoms were significantly associated with standard
deviation of wake times, t(42) = 2.06, p = .045 . Higher depressive symptoms among individuals
were associated with lower levels of consistency in waking up at the same time every day.
Anxiety symptoms, employment status, number of co-occurring physical health problems,
insurance status, and marital status were not associated with consistency in wake times (see
Table 9).
Need factors. No need factors were associated with consistency in wake times (see Table
9).
Combined model. A multiple linear regression model was conducted where age was

ATTENDANCE AND ADHERENCE IN INSOMNIA TREATMENT

33

entered into step one and depressive symptoms were entered into step two of the model. In step
one of the model, age was significantly associated with standard deviation in wake time, t(42) = 2.21, p = .03, with the R-square for the model being .10. In step two of the model, age and
depressive symptoms were not significant, t(41) = -1.61, p = .12; t(41) = 1.41, p = .16;
respectively, with the r-square for the model increasing to .15 (see Table 10).
Discussion
The present study investigated whether the following predisposing factors (age, gender,
ethnicity, education level), enabling factors (employment status, insurance status, marital status,
anxiety symptoms, and depressive symptoms), and need factors (sleep problem severity) were
associated with individuals’ attendance of Cognitive Behavioural Therapy for Insomnia (CBT-I)
and adherence to treatment recommendations of the therapists (i.e., adhering to a consistent bed
time and wake time). Individuals who met inclusion criteria attended an average of 3.4 treatment
sessions and 26 individuals out of the 108 individuals in this study completed all recommended
treatment sessions. During the first week that participants were recommended to adhere to a
consistent sleep and wake time (i.e., going to bed at the same time every day and getting out of
bed at the same time every day), individuals deviated from a consistent bed time by 27 minutes
and deviated from a consistent wake time by 40 minutes. The number of individuals who
completed treatment was lower than what has been commonly found in the literature for CBT-I
treatment, which typically indicates a completion rate of 50% to 66% among studies recruiting a
community sample using relaxed inclusion and exclusion criteria (Espie et al., 2008; Espie et al.,
2007; Morgan et al., 2003). The number of minutes that individuals deviated from a consistent
bed and wake time was similar to what has been reported in previous studies (e.g., 28 minutes,
Riedel & Lichstein, 2001).
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Consistent with a prior study of CBT-I treatment (Vincent et al., 2008), age was
associated with treatment attendance in the present study with older adults being more likely to
attend three or more treatment sessions as well as to complete CBT-I treatment. Older
individuals were also more consistent in going to bed at the same time every night as well as
getting out of bed at the same time every morning. CBT-I treatment is heavily structured and
didactic in nature and younger patients may prefer to have a more active role in their treatment
(Bosworth et al., 2006), which may explain why younger adults were less likely to attend CBT-I
treatment and adhere to treatment recommendations. Older age may facilitate successful
utilization of treatment through increases in conscientiousness. The personality trait of
conscientiousness increases over the life span with the greatest increase shown in facets of
impulse control (higher levels of cautiousness and lower levels of carelessness) and reliability
(higher levels of dependability and lower levels of unreliability; Jackson et al., 2009). The
finding that older adults more reliably show up to treatment and resist urges to deviate from a set
bed and wake time may be due in part to older adults having a higher level of conscientiousness
on average as compared to younger adults. Tailoring treatments to individual characteristics has
been shown to improve treatment utilization (Bosworth et al., 2006). For example, tailoring
health messages promoting mammography to an individual’s style of coping was more effective
than untailored messages (Williams-Piehota, Pizarro, Schneider, Mowad, & Salovey, 2005).
Future studies may investigate mediators of the relationship between age and treatment
utilization, such as level of conscientiousness, in order to design a CBT-I treatment program that
is more tailored towards the preferences and needs of younger adults.
According to the Health Belief Model, an individual’s decision to attend treatment and
adhere to treatment recommendations is influenced by their perception of barriers that will
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hinder their ability to utilize treatment successfully (Martin et al., 2010). Individuals may
perceive having more co-occurring symptoms of other mental health disorders (e.g., depression,
anxiety) as barriers to their ability to utilize CBT-I treatment successfully. The present study
found lower levels of anxiety and depressive symptoms to be associated with greater likelihood
of attending three or more sessions and completing all recommended sessions of CBT-I
treatment. Additionally, less depressive symptoms were associated with less deviation in wake
times. Symptoms of depression such as low energy may hinder an individual’s ability to
physically attend session as well as physically comply with various treatment recommendations
such as getting out of bed at a consistent time every morning (Smith, Huang, & Manber, 2005).
Additionally, cognitive symptoms of depression such as pessimism may negatively impact an
individual’s perceived ability to attend treatment, follow treatment recommendations, or benefit
from treatment even if they do attend all sessions and follow all recommendations.
Individuals with high levels of anxiety may be less likely to utilize a treatment that
recommends restricting sleep so that they would be sleeping even less than ever before. These
individuals are likely already very worried about the negative impact of limited sleep and likely
possess several catastrophizing beliefs related to not getting enough sleep (Smith et al., 2005).
Unfortunately, cognitive restructuring occurs near the end of the treatment, while sleep
restriction occurs near the beginning of the treatment. Consequently, anxious individuals who are
already worried about the negative impact of their limited sleep may have been more likely to
attend only two or fewer sessions before dropping out since it is in the second session that they
are presented with the treatment rationale which includes recommendations to restrict sleep even
further (Smith et al., 2005). Among individuals who did attend treatment, however, anxiety
symptoms did not appear to hinder an individual’s ability to comply with treatment
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recommendations (i.e., follow a consistent bed and wake time). It may be that highly anxious
people are more skeptical of the treatment and may be less likely to buy into the rationale and
decide to remain in treatment. However, among anxious individuals who came to treatment,
higher anxiety symptoms did not appear to hinder their ability to adhere to treatment
recommendations.
Depression and anxiety symptoms are highly comorbid with symptoms of insomnia
(Espie et al., 2007; Taylor, Lichstein, Durrence, Reidel, & Bush, 2005). Given the negative
impact of co-occurring depression and anxiety symptoms on CBT-I treatment attendance, these
symptoms should be assessed in all individuals seeking insomnia treatment. To facilitate better
treatment attendance, clinicians may work with the individual to determine whether the cooccurring symptoms may negatively impact treatment attendance and refer the individual to
obtain treatment for their depression or anxiety before beginning CBT-I treatment. The
symptoms of depression and anxiety may also hinder motivation to utilize CBT-I treatment and
thus additional time spent assessing and securing buy-in from these individuals may be
warranted. Providing didactics on the importance of getting insomnia treated as it is a risk factor
for developing depressive or anxiety disorders (Neckelmann et al., 2007; Riemann &
Voderholzer, 2003) and the treatment of which may improve co-occurring mental health
symptoms (Manber et al., 2008) may assist in increasing buy in from individuals with co-morbid
anxiety and/or depressive symptoms. Additionally, the use of motivational interviewing prior to
treatment may also facilitate attendance and adherence among these individuals (VanBuskirk &
Wetherell, 2014).
The Health Belief Model states that an individual’s decision to utilize treatment is
influenced by their perception of need for treatment (e.g., perceived symptom severity and/or
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severity of prognosis of their disease; Martin et al., 2010). The present study found that
individuals with lower insomnia symptoms at the beginning of treatment were more likely to
complete all recommended treatment sessions, which is inconsistent with the Health Belief
Model. However, insomnia symptom severity was not associated with likelihood of completing
three or more sessions or with the number of sessions attended among individuals who did not
attend all recommended sessions. The findings in the literature regarding baseline sleep problem
severity and attendance are also mixed, with two studies indicating that greater sleep problems at
the beginning of treatment (i.e., greater fatigue, Dashevsk & Kramer,1997; and lower total sleep
time, Ong et al., 2008) were associated with greater attrition and one study indicating that less
sleep disturbance at baseline was associated with greater attrition (Morgan et al., 2003).
Additionally, other measures of sleep problems used in our study (i.e., sleep problem severity,
PSQI, and daytime sleepiness, ESS) were not associated with attendance. These findings suggest
that pre-treatment sleep problem severity may not be a reliable predictor of treatment attendance.
It is important to note that this study investigated a broad range of potential predictors
(predictors that may predispose an individual to utilize treatment, enable an individual to utilize
treatment, signal a need to the individual to utilize treatment) with very few predictors being
found to be associated with attendance of CBT-I treatment or adherence to CBT-I
recommendations. Gender, ethnicity, and level of education, factors that may predispose
individuals to utilize treatment, were not associated with attendance or adherence in this
treatment study. Additionally, employment status, insurance status, marital status, and number of
co-occurring health problems, factors that may help enable an individual to utilize treatment,
were also not found to be associated with attendance and adherence. Co-occurring depression
and anxiety symptoms did not predict adherence and did not predict attendance over and above
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age. Lastly, factors that may signal to the individual that there is a need to seek out treatment
showed limited and inconsistent relations to attendance and adherence. These findings suggest
that patient factors are limited in their utility in predicting CBT-I treatment utilization. Patient
factors are also the most commonly investigated predictors of CBT-I treatment utilization (e.g.,
Bouchard et al., 2003; Manber et al., 2011; Vincent et al., 2008). Given their limited utility,
clinicians have recommended investigating factors associated with the therapist or the treatment
that may influence treatment utilization (Bosworth et al., 2006).
Past psychotherapy research has indicated that individuals were more likely to attend
treatment if they had a stronger therapeutic alliance with their therapist (Keller, Zoellner, &
Feeny, 2010; Simpson, Joe, Rowan-Szal, & Greener, 1997; Taft et al., 2003). A better
therapeutic alliance was also associated with increased compliance with recommended
homework (Taft, Murphy, King, Musser, & DeDeyn, 2003). Psychotherapy studies have found a
number of therapist characteristics associated with retention of patients include being female,
older, more motivated, more caring, and more experienced (Swift & Greenberg, 2012, Tryon,
1985; Tryon, 1989; Tryon & Tryon, 1986). Patients were also more likely to comply with
treatment recommendations if their therapist was female and more skilled (Bryant et al., 1999).
To date, no CBT-I treatment studies have investigated therapist factors (e.g., therapist gender,
therapist skill) and treatment factors (e.g., therapeutic alliance) associated with CBT-I attendance
and adherence to CBT-I recommendations. The limited success of CBT-I treatment studies to
identify patient characteristics that consistently predict treatment utilization provide support for
the need to investigate therapist and treatment factors to find consistent predictors of CBT-I
treatment utilization.
The present study has several limitations that may influence the interpretation and
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generalizability of the findings. The sample was primarily Caucasian and thus findings may not
generalize to more heterogeneous samples. Added caution is warranted with respect to
interpreting the nonsignificant relation between ethnicity and attendance and adherence as 92%
of the sample was Caucasian. All therapies were provided by first and second year clinical
psychology graduate students and thus caution is warranted in generalizing the findings of this
study to CBT-I treatments carried out by more experienced psychotherapists. Of note, all student
therapists were supervised by a licensed clinical psychologist certified in behavioural sleep
medicine. Attrition levels were higher in the present study as compared to what is generally seen
in CBT-I treatment, which may be due in part to the fact that all treatments were carried out by
graduate students early in their training. The limited number of participants in the treatment
completion group meant that there was insufficient power to analyse predictors of treatment
completion in multivariate analyses to determine if the predictors that were significant in
univariate analyses would still contribute unique predictive utility in multivariate analyses. The
biographical questionnaire assessing relationship status did not provide an option to select living
together and thus the present study was not able to investigate the relation between cohabitation
and treatment utilization. This information should be considered when interpreting the results of
the analyses investigating the relation between marital status and treatment utilization.
Replication of the findings of the study, in particular with respect to predictors of treatment
completion, is warranted. Despite these limitations, the present study fills a gap in the literature
by systematically investigating a broad array of factors that may be associated with CBT-I
treatment attendance and adherence using a heterogeneous community sample of adults with
insomnia disorder. The study utilized few inclusion and exclusion criteria in order to ensure the
recruitment of a heterogeneous treatment seeking sample which provides support for the
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generalizability of our findings.
The present study investigated factors associated with attending CBT-I and adhering to
CBT-I treatment. Older adults and individuals with less co-occurring depression and anxiety
symptomology were more likely to attend treatment and older adults were also more likely to
adhere to treatment recommendations of maintaining a consistent bed and wake time. Assessing
and addressing co-occurring mental health problems through treatment or referral may improve
CBT-I treatment retention. Research identifying mediators of the relation between age and
treatment utilization and designing CBT-I treatments tailored towards the needs of younger
adults may improve retention of younger adults and their adherence to treatment
recommendations.
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Table 1.
Demographic Characteristics of the Sample
Frequency
Predisposing Factors
Age
Gender
Female
77
Male
31
Ethnicity
Non-Hispanic Caucasian
100
African American
4
Hispanic American
1
Asian American
2
Other
1
Education
Less than high school
8
High school
16
Some college
20
Four year college
27
Graduate school
35
Enabling Factors
Employment
Working
56
Not working
17
Retired
20
Disabled
14
Insurance
Private
80
Medicare
17
Medicaid
11
Marital Status
Married
48
Not married
60
Number of health problems
Beck Anxiety Inventory
Center for Epidemiologic
Studies Depression Scale-Revised
Need Factors
Pittsburgh Sleep Quality Index
Epworth Sleepiness Scale
Insomnia Severity Index

(%)

57

M

SD

50.45

14.63

N
108
108

71.30%
28.70%
108
92.60%
3.70%
0.90%
1.90%
0.90%
106
7.40%
14.80%
18.50%
25.00%
32.40%
107
51.90%
15.70%
18.50%
13.00%
108
74.10%
15.70%
10.20%
108
44.40%
55.60%
3.80
13.45

3.25
10.94

108
101

18.83

12.86

103

14.11
7.54
19.69

3.42
5.98
4.58

100
105
103
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Table 2.
Group vs Individual Cognitive Behavioral Therapy for Insomnia
Group
Individual
Attendance
N (%)
N
Three or more sessions
3 (43%)
47 (47%)
All sessions
0 (0%)
26 (26%)
Adherence
Consistency of Bed Times
Consistency of Wake Times

M(SD)
27.54 (16.19)
55.13 (7.57)

M(SD)
27.05 (29.85)
39.30 (26.47)
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Table 3.
Correlation among Continuous Predictor Variables
1. Age
2. Number of Health Problems
3. Beck Anxiety Inventory

Center for Epidemiologic

4. Studies Depression Scale-Revised

2.
.30**
-

3.
-.20*
.31**
-

4.
-.32**
.16
.77**

5.
-.14
.26**
.45**

6.
-.07
.21*
.03

7.
-.07
.36**
.50**

-

.53**

.17

.53**

-

.09
-

.55**
.09
-

5. Pittsburgh Sleep Quality Index
6. Epworth Sleepiness Scale
7. Insomnia Severity Index
Note. * = p < .05, ** = p < .01, N varies between 103 and 108 due to missing data
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Table 4.
Attended Three or More Sessions vs Two or Fewer Session
N
Wald Chi-Square
Predisposing
108
7.43
Age
108
0.33
Gender
108
3.07
Ethnicity
106
0.38
Education
Enabling
Employment
Insurance
Marital Status
Number of Health Problems
Beck Anxiety Inventory
Center for Epidemiologic
Studies Depression Scale-Revised

p
< .01
.56
.08
.54

107
108
108
108
103

6.02
0.36
1.56
0.77
7.53

.11
.84
.21
.38
< .01

107

5.95

.01

Need
104
0.52
Pittsburgh Sleep Quality Index
107
0.003
Epworth Sleepiness Scale
105
1.80
Insomnia Severity Index
Note. All analyses were separate bivariate logistic regressions

.47
.96
.18

60
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Table 5.
Predicting Attending Three or More Sessions
Hierarchical Logistic Regression
Step 1.
Age
Step 2.
Age
Beck Anxiety Inventory

-2LL
140.822

B

SE

.04

.01

.04
-.07

.02
.03

133.32

Wald ChiSquare
7.43
7.43
11.89
5.27
4.05

Center for Epidemiologic
.01
.03
0.29
Studies Depression Scale-Revised
Note. Hierarchical logistic regression with age entered into step one and anxiety and
depression symptoms entered into step two of model

p
< .01
< .01
< .01
.02
0.0497
.62
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Table 6.
Attended All Sessions vs Did Not Attend All Sessions
N
Wald Chi-Square
Predisposing
108
10.51
Age
108
1.47
Gender
108
0.002
Ethnicity
106
1.01
Education
Enabling
Employment
Insurance
Marital Status
Number of Health Problems
Beck Anxiety Inventory
Center for Epidemiologic
Studies Depression Scale-Revised

62

p
< .01
.23
.97
.31

107
108
108
108
103

4.74
0.75
0.43
0.45
5.15

.19
.69
.51
.50
.02

107

7.97

< .01

Need
104
0.21
Pittsburgh Sleep Quality Index
107
0.005
Epworth Sleepiness Scale
105
5.37
Insomnia Severity Index
Note. All analyses were separate bivariate logistic regressions

.65
.94
.02
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Table 7.
Number of Sessions Attended among Treatment Non-completers

N

B

SE

p

82
82
82
80

0.03
0.22
0.87
0.32

0.01
0.43
0.67
0.47

.03
.61
.20
.50

81
82
82
82
78

-0.27
0.04
-0.68
-0.01
-0.03

0.17
0.28
0.40
0.06
0.02

.13
.88
.09
.84
.07

81

-0.01

0.02

.42

Need
78 -0.07
0.06
Pittsburgh Sleep Quality Index
Epworth Sleepiness Scale
81 -0.02
0.03
79
0.01
0.05
Insomnia Severity Index
Note. All analyses were separate bivariate linear regressions

.25
.61
.86

Predisposing
Age
Gender
Ethnicity
Education
Enabling
Employment
Insurance
Marital Status
Number of Health Problems
Beck Anxiety Inventory
Center for Epidemiologic
Studies Depression Scale-Revised
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Table 8.
Consistency of Bed Times
Predisposing
Age
Gender
Ethnicity
Education
Enabling
Employment
Insurance
Marital Status
Number of Health Problems
Beck Anxiety Inventory
Center for Epidemiologic
Studies Depression Scale-Revised

N

B

SE

p

44
44
44
44

-0.71
-3.65
3.71
5.89

0.28
10.54
21.23
11.43

.01
.73
.86
.61

44
44
44
44
42

-3.16
0.50
-4.93
0.15
0.13

4.69
8.09
8.90
1.52
0.40

.50
.95
.58
.92
.74

44

0.72

0.37

.06

1.24
0.84
0.98

.29
.84
.16

Need
43
1.34
Pittsburgh Sleep Quality Index
44
-0.18
Epworth Sleepiness Scale
44
1.39
Insomnia Severity Index
Note. All analyses were separate bivariate linear regressions
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Table 9.
Consistency of Wake Times
N

SE

p

44
44
44
44

-0.56 0.25
-7.00 9.36
0.08 18.96
-6.07 10.20

.03
.46
.997
.56

44
44
44
44
42

1.74
3.11
-7.46
-0.68
0.27

4.20
7.21
7.89
1.36
0.46

.68
.67
.35
.62
.56

44

0.68

0.33

.045

Need
43
0.53 1.12
Pittsburgh Sleep Quality Index
44
-0.004 0.75
Epworth Sleepiness Scale
44
0.33 0.90
Insomnia Severity Index
Note. All analyses were separate bivariate linear regressions

.64
.996
.72

Predisposing
Age
Gender
Ethnicity
Education
Enabling
Employment
Insurance
Marital Status
Number of Health Problems
Beck Anxiety Inventory
Center for Epidemiologic
Studies Depression Scale-Revised

B
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Table 10.
Predicting Consistency of Wake Times
Hierarchical Linear Regression
Step 1.
Age
Step 2.
Age
Center for Epidemiologic
Studies Depression Scale-Revised

R-Square
.10
.15

F
4.89

66

B

SE

t-Value

-.56

.25

-2.21

-.43

.27

-1.61

p
.03
.03
.04
.12

.49

.35

1.41

.16

3.50

DF
42
41

Note. Hierarchical linear regression with age entered into step one and depression symptoms entered into
step two of model
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